Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Diseases

Explore clinical trials studying Pancreatic Diseases. Study availability and eligibility vary by location and protocol.

4,387 public trials 842 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Diseases trial results

Completed

Study of XB002 in Subjects With Solid Tumors (JEWEL-101)

NCT04925284

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +57 more
Locations
  • Exelixis Clinical Site #48 Birmingham, Alabama, United States
  • Exelixis Clinical Site #20 Tucson, Arizona, United States
  • Exelixis Clinical Site#95 Tucson, Arizona, United States
  • Exelixis Clinical Site#58 Little Rock, Arkansas, United States
View all 95 locations
View Trial Details
Completed

Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)

NCT04330664

Conditions
Advanced Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +28 more
Locations
  • Local Institution - 002-805 Los Angeles, California, United States
  • Local Institution - 002-803 Orange, California, United States
  • Local Institution - 002-828 Chicago, Illinois, United States
  • Local Institution - 002-942 Wichita, Kansas, United States
View all 17 locations
View Trial Details
Completed

BPM31510 Administered Intravenously With Gemcitabine in Advanced Pancreatic Cancer Patients

NCT02650804

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Banner Health Gilbert, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • Global Cancer Research Institute, Inc. Gilroy, California, United States
  • Sarcoma Oncology Research Center Santa Monica, California, United States
View Trial Details
Completed

A Study to Find a Safe and Effective Dose of BI 905711 in Patients With Advanced Gastrointestinal Cancer

NCT04137289

Conditions
Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +12 more
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • START South Texas Accelerated Research Therapeutics, LLC San Antonio, Texas, United States
View all 18 locations
View Trial Details

Related conditions